Vicam

Quick links to important sections

Vicam

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vicam

What is Vicam? Definition and Classification

Property Description
Active ingredient Full spectrum of B-Group Vitamins (Thiamine, Riboflavin, Pyridoxine, Cobalamin, etc.)
Form Oral Tablet/Capsule and Sterile Solution
Pharmacological class Water-soluble Vitamins; Nutritional Supplement
Common use Metabolic Support
Origin Derived (Synthetic/Fermentation)

Vicam is a pharmaceutical preparation classified as a multi-component nutritional supplement belonging to the broad Pharmacological Class of Water-soluble Vitamins. As a fixed-combination product, it delivers multiple essential B-vitamins simultaneously, a composition clinically recognized for comprehensive deficiency management. This confirms that the primary function of this preparation is to supply essential micronutrients for the body’s core processes. Vicam, as a specific formulation, often distinguishes itself by emphasizing a balanced profile of the eight B vitamins, suitable for addressing common adult nutritional gaps resulting from restricted diets or high metabolic demand.


Composition and Available Forms of Vicam

The preparation's active ingredients include the full spectrum of B-vitamins, such as Pyridoxine (B6), Folate (B9), and Niacin (B3), compounds which the human body generally cannot synthesize sufficiently on its own. These vitamins are primarily derived—produced through synthetic or fermentation processes—to achieve the necessary purity and stability for pharmaceutical use. Vicam is particularly known for offering both solid oral forms, such as the Tablet or Capsule, and a high-strength Sterile Solution intended for direct Intramuscular or Intravenous administration in clinical settings. The availability of the injectable form addresses scenarios where rapid restoration of these cofactors is necessary.


General Role: Why is Vicam Used?

The general role of Vicam is to support the body’s numerous metabolic pathways where B-vitamins function as Coenzyme Precursors. For instance, B-vitamins are crucial for facilitating the enzymatic reactions that allow the body to convert energy from food, directly contributing to Energy Metabolism. By ensuring the sustained availability of these key micronutrients, the preparation helps maintain the structural health and integrity of cells, particularly those involved in Nervous System Integrity and cell renewal processes like Hematopoiesis. A typical use scenario involves supplementing the diet of adults to ensure optimal nerve function and energy production.

Regulatory References

  1. MedlinePlus

What side effects are possible with Vicam?

Possible Side Effects and Safety Information

The officially documented safety profile for Vicam, a multi-component preparation of water-soluble B-group vitamins, is characterized by effects categorized by frequency and the organ system involved. This information is derived strictly from government regulatory documents.

Adverse Reaction Classification

Category Description
Common Adverse reactions frequently listed in regulatory documents include nausea, vomiting, diarrhea, and headache. Reactions affecting the skin, such as flushing and non-severe rash, are also categorized as common.
Uncommon/Rare Less frequently documented effects involve hypersensitivity reactions (allergic responses), including urticaria and pruritus (itching).
Serious Adverse Reactions Regulatory documents list anaphylactic reactions (anaphylaxis) as a rare but serious possible event. Severe peripheral neuropathy is also noted, tied specifically to chronic, high-dose exposure to the Pyridoxine (Vitamin B6) component.

Population-Specific Safety Considerations

The safety profile includes specific limitations. Use is contraindicated in patients with a documented hypersensitivity to any component of Vicam. Caution is advised for individuals with severe renal impairment due to the metabolic route of water-soluble vitamins. The product is also contraindicated in patients with Leber's disease due to the Vitamin B12 component.

Time and Dose-Related Safety Patterns

The risk of peripheral neuropathy is explicitly linked to long-term exposure at higher doses of Pyridoxine. Conversely, minor gastrointestinal effects may be more prominent at the initiation of treatment. For the injectable form, pain and swelling at the injection site are common, immediate, short-term local reactions.

Overdose and Emergency Response

Overdose manifestations for Vicam, a multi-component water-soluble vitamin preparation, are primarily focused on neurological effects due to high exposure to Pyridoxine (Vitamin B6). Documented clinical manifestations of overexposure include peripheral sensory neuropathy, frequently presenting as paresthesia (tingling, burning, or numbness in the extremities), ataxia (lack of coordination), and muscle weakness. Should these signs of nerve injury appear, regulatory information mandates that the patient stop taking the preparation immediately and seek medical advice from a healthcare professional.

Overexposure to the high-strength sterile solution (parenteral form) carries severe acute risks. These life-threatening outcomes include reported cases of anaphylactic shock and specific cardiovascular effects, such as pulmonary edema. Any sudden or severe systemic event requires immediate medical attention.

Treatment procedures are strictly defined as symptomatic management and supportive care, as regulatory documents state that no specific antidote is known for Pyridoxine toxicity. Population-specific notes also exist: patients with impaired kidney function face a risk of aluminum accumulation with prolonged parenteral use, and the injectable form is associated with specific risk to premature neonates.

Therapeutic Uses of Vicam

What Vicam Treats: Main Uses and Benefits

Vicam is primarily used for symptomatic relief across domains of discomfort, targeting acute and disruptive episodes. The class of medication to which Vicam belongs is commonly used to help manage pain, inflammation, and fever.

The medication is relevant for easing symptoms in conditions characterized by episodic or fluctuating symptom patterns, such as discomfort from headaches, muscular stiffness, joint aches, and fever associated with common acute illnesses. It helps address symptom clusters that interfere with daily comfort.

“Vicam provides supportive relief, assisting with symptoms that create noticeable functional strain.”

By providing this support, the medication helps ease the overall symptom burden during periods of heightened symptoms and supports patients during difficult episodes.

Quick Fact: Relief for Pain, Fever, and Inflammation

This support is relevant when temporary symptomatic assistance is needed, and may help patients cope more steadily with symptom fluctuations when physical symptoms become more noticeable.

Eligibility and Restrictions for Use

The official eligibility profile for Vicam is defined by populations that are explicitly restricted or prohibited from using the medicine based on established risks and insufficient data, as documented in governmental regulatory labeling.

Populations Who Must Not Use Vicam

Vicam is contraindicated in patients with a history of known hypersensitivity to the active substance or to any inactive component (excipient) in the formulation. Use in these individuals is absolutely prohibited due to the risk of severe allergic reactions. The drug is also contraindicated during pregnancy, as safety has not been established and potential risks to the fetus may exist.

Populations With Use Restrictions

The safety and effectiveness of Vicam have not been established in pediatric patients (under 18 years of age), making this population ineligible for treatment under the authorized label. Use is not recommended for patients with severe hepatic impairment due to the potential for significant drug accumulation. Additionally, patients with moderate to severe renal impairment require special consideration and close clinical monitoring, often necessitating dose modifications to manage exposure.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Vicam's interaction profile is documented in regulatory sources based on the effects of its individual B-vitamin components with specific medicines and substances.

Classification Interacting Substance/Class
Contraindicated Combination Levodopa (when taken without a peripheral decarboxylase inhibitor)
Pharmacodynamic Antagonism Folic Acid Antagonists (e.g., Methotrexate, Pyrimethamine)
Exposure-Altering Agents Acid-Reducing Agents, Cycloserine, Chloramphenicol

The most significant restriction documented is the contraindication for co-administration of the Pyridoxine (B6) component with Levodopa alone, as B6 is officially stated to accelerate the drug's peripheral metabolism, reducing its systemic availability.

Folate (B9) is documented to exert pharmacodynamic antagonism against agents like Methotrexate, thereby affecting the intended function of those medicines. The exposure of certain Vicam components is also subject to pharmacokinetic interference; chronic use of acid-reducing agents is documented to reduce the oral absorption of Cobalamin (B12). Separately, substances like Cycloserine and Chloramphenicol are officially stated to interfere with the utilization or increase the requirement for Pyridoxine (B6) and Cobalamin (B12), respectively.

Furthermore, regulatory sources document a substance-drug interaction with chronic heavy alcohol consumption, which interferes with the body's metabolism and increases the clearance of the Thiamine (B1) and Folate (B9) components.

Mechanism of Action

How Vicam Works: Mechanism of Action


Modulating Cerebral Blood Flow

Vicam acts as a targeted cerebral vasodilator, engaging with receptors on the smooth muscle walls of brain arteries to promote relaxation and widening. This mechanistic domain results in an increased supply of oxygen and glucose to the central nervous system, influencing basic cell function.


Influencing Neuro-Metabolism

The molecule modulates intracellular enzymatic systems, influencing the rate of utilization of oxygen and glucose by brain cells. This action directly supports higher cellular energy production (ATP), influencing energy substrate availability, which contributes to the state of neural network processes and complex signaling.


Mediating Cellular Stress Mechanisms

Vicam exhibits cell-level effects by neutralizing harmful free radicals (antioxidant effect) and modulating specific pathways (like NF-kappaB) involved in stress signaling. This mechanism mediates the stabilization of neuronal membranes and influences the mitigation of damage, affecting the functional status of brain tissue.

Dosage and Administration Information

Vicam is officially approved for administration via two primary routes: oral intake as a tablet or capsule, and parenteral injection using a sterile solution. The injectable form may be administered via the intramuscular (IM) route or as a slow intravenous (IV) injection.

Usage is characterized by distinct patterns and dosage ranges based on the intended purpose. The dose for daily prophylactic or maintenance use is typically lower than the range specified for active therapeutic treatment. For oral forms, the general frequency is once daily, often directed to be taken with a little liquid during or after meals to support absorption. For parenteral use, the administration pattern is structured into an initial loading phase involving frequent dosing (e.g., daily or on alternate days), followed by a long-term maintenance phase where injections are given at extended intervals, such as weekly or monthly.

Specific procedural requirements must be followed for the injectable solution. High-concentration solutions intended for the IV route require dilution in a compatible parenteral solution prior to administration. Furthermore, the IV injection must be administered slowly. Separate dosing rules are established for certain populations; for instance, pediatric populations have specific, lower daily dosage regimens compared to adult use. If an appointment for an injection is missed, the instruction is to contact the healthcare provider to determine when the next dose should be scheduled.

Recent Clinical Evidence

Vicam: Recent Clinical Evidence

Research into multi-component B-vitamin preparations, like Vicam, focuses on two main areas: exploring documented nutritional shortfalls and examining the role of these nutrients in key body systems like the nerves and metabolism. This evidence is drawn from official Randomized Controlled Trials (RCTs), where one group receives the preparation and another receives a placebo or comparator, as well as broader Systematic Reviews that analyze many studies at once.


Evidence for Correction of Documented Deficiencies

Researchers applied B-vitamin combinations in studies to populations that had documented low levels of specific B-vitamins. The main outcomes research examined involved outcomes measuring the change in the concentration of B-vitamins in the blood and shifts in key metabolic indicators, such as homocysteine. Findings consistently show that these preparations describe patterns related to the normalization of specific B-vitamin levels in the serum of individuals with a deficiency. While evidence is high for correcting these biochemical shortfalls, research has limited information for long-term outcomes regarding the association with overall functional health following initial correction.


Evidence for Cognitive Function and Neural Integrity

Research explored whether B-vitamin combinations was evaluated in specific groups, primarily older adults, including those with mild cognitive impairment. These were often long-term, large-scale RCTs that monitored changes in standardized cognitive performance scores and brain structure. Findings from these trials were often mixed and varied across different study groups. Some research described patterns where a slower rate of change in brain atrophy was observed in specific subgroups. The overall certainty remains low for a broad, consistent effect across all older adult populations. Results apply only to the populations studied.


Evidence for Generalized Fatigue and Functional Status

Studies explored how the preparation was studied for outcomes related to systemic or functional imbalance, such as persistent tiredness. Trials were generally short- to intermediate-term and primarily used patient-reported outcomes (fatigue scales). Findings from research exploring short-term symptom changes were mixed. Individual high-quality studies often did not find a statistically significant difference in reducing the severity of fatigue when compared to a placebo. A key limitation is the high degree of variation (heterogeneity) across study designs and the reliance on subjective outcomes.

Frequently Asked Questions (FAQ)

Common questions about Vicam (FAQ)

Q: Can Vicam cause weight gain or weight loss?

The officially documented adverse effects listed for Vicam do not commonly include changes in body weight or appetite. Studies examining the individual B-vitamin components have explored their effects on metabolism and glucose response.

Q: Is Vicam known to make you feel tired or dizzy?

Official regulatory documentation for Vicam lists headache as a common side effect. Less frequent effects are described, and official safety information for certain B-vitamin components, such as Niacin (B3), has described effects on the central nervous system.

Q: Can taking Vicam affect sleep or cause insomnia?

The drug's formal safety profile, derived from regulatory data, does not list insomnia (trouble sleeping) as a common or rare adverse reaction. However, research exploring the use of B-group vitamins in certain populations has examined relationships between B-vitamin levels and sleep quality.

Q: Does Vicam interact with birth control pills?

Drug-drug interaction profiles describe specific warnings for certain types of medications. Official documents advise consulting the complete product documentation for a full review of all known interactions, which may include hormonal preparations.

Q: Can Vicam be used by people with diabetes?

The regulatory profile specifically advises caution for patients who have severe renal (kidney) impairment. Research studies have explored the role of B-vitamin complex supplementation in specific diabetic populations, focusing on outcomes related to blood markers and glycemic control.

Q: What kind of regular monitoring is mentioned in the research for Vicam?

Regulatory safety documentation advises that patients with moderate to severe renal impairment may require close clinical monitoring. Research protocols often describe the monitoring of B-vitamin concentrations in the blood and specific metabolic indicators.

Q: Is the full effect of Vicam immediate or gradual?

The use of the injectable form is structured into an initial loading phase followed by a long-term maintenance phase. Clinical research often documents a slower rate of change in observed outcomes, indicating that the full effects are typically gradual and not immediate.

Q: Can I drive or operate machinery while using Vicam?

The list of common side effects does not typically include severe neurological effects that would mandate an official driving restriction. Individual responses to any medication can vary, and regulatory documentation typically suggests noting personal response before operating machinery.

Q: Do you have to gradually stop taking Vicam?

Information regarding the cessation of the medication is specific to individual circumstances and is described in consultation with a healthcare provider.

Q: What does the research say about quality of life improvements with Vicam?

Research has utilized patient-reported outcomes to explore the effects of the drug on subjective status, such as fatigue and functional health. These findings are often part of a broader discussion of overall functional health and well-being.

Q: Do you always have to take Vicam at the exact same time every day?

The oral dosage regimen for Vicam is typically described as being taken once daily. Official product information describes the importance of following a consistent daily schedule to help maintain stable levels of the B-vitamins.

Q: Are there any dietary restrictions or foods to avoid while using Vicam?

Official interaction documentation specifically notes interference with chronic heavy alcohol consumption and certain acid-reducing agents. No general food or dietary restrictions beyond instructions to take the oral form during or after meals are commonly documented.

Q: Why does the information say Vicam is for 'long-term conditions'?

Vicam is classified as a nutritional supplement designed to support long-term metabolic and nervous system integrity. Its role often relates to correcting nutritional shortfalls that may be chronic or managing conditions that require sustained cofactor availability.

Q: What happens if you miss a dose of Vicam?

If an oral dose is missed, the instruction is typically to take the dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed. The instruction provided is that the dose should not be doubled.

Q: Can Vicam be split or crushed for easier swallowing?

The official patient information for the tablets or capsules describes the approved method of administration. Unless instructions specifically permit splitting or crushing, the formulation is intended to be taken whole to maintain the correct release profile.

Q: Is there a risk of dependence associated with Vicam?

Vicam is classified as a multi-component water-soluble vitamin supplement. Regulatory documents that define safety profiles do not list the drug as having a known risk of dependence or abuse potential.

Q: Can people who are lactose intolerant use Vicam tablets?

The official regulatory documentation for the drug lists all inactive components (excipients) in the tablets. For patients with a known intolerance, such as lactose intolerance, the excipient list provided in the official patient information leaflet is the source for review.

Q: Does the strength of the tablet relate to the severity of the condition?

The strength and dosage of Vicam prescribed is primarily related to the specific medical purpose, such as correcting a documented deficiency or serving as a maintenance supplement. It is not necessarily a direct measure of symptom severity.

Q: Can Vicam be used for short periods?

Regulatory documentation describes different usage patterns, including a structured initial loading phase involving frequent dosing for rapid correction. This initial phase can be considered a shorter period of use compared to the long-term maintenance phase.

Q: Are there warnings about Vicam and sun exposure?

The officially documented adverse reaction profile does not commonly list photosensitivity (severe skin reaction to sunlight). However, users are advised to review the complete list of skin reactions, such as rash and flushing, documented in the patient leaflet.

Q: Can teenagers use Vicam for the approved condition?

The safety and effectiveness of Vicam have not been established in pediatric patients (under 18 years of age). Regulatory labeling indicates that the drug is not authorized for use in the teenage population under the current official label.

Q: Is the package insert for Vicam the same across all countries?

The content regarding the drug's core safety and efficacy profile is generally aligned among major international regulatory agencies. However, minor and major variations to the package insert are permitted based on local regulatory requirements and approvals.

Q: Does Vicam affect fertility in men or women?

The regulatory safety profile must include documented effects on fertility if they are established. Additionally, research has explored the influence of individual B-vitamins, such as Vitamin B12, on aspects of reproductive health.

How should Vicam be stored and disposed of?

Vicam, particularly the sterile injectable solution, has mandatory storage conditions to maintain its potency and integrity, as required by regulatory labeling.

Official Storage and Handling

Requirement Type Condition
Storage Temperature Refrigerate between 2 C to 8 C (36 F to 46 F).
Light/Freezing Protect from light; Do not permit to freeze.
Container/Handling Store upright in the original carton until use; visually inspect for particles before administration.
Child-Safety Keep out of the sight and reach of children.

Disposal Instructions

Unused or expired Vicam should be disposed of in accordance with local regulations, utilizing a community drug take-back program if available. If no take-back program is accessible, remove the medicine from its original container, mix it with an undesirable substance (like dirt or used coffee grounds), seal the mixture in a container, and discard it in the household trash. Used needles and syringes must be placed immediately into an FDA-cleared sharps container and not disposed of in household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Vicam found in:

A-Z Index: